DOCSLIB.ORG

Guide to Authors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Guide to Authors Guide for Authors About the Journal ...................................................................... 1 Costs............................................................................................. 8 Article Type Specifications ....................................................... 2 Editorial Policies ......................................................................... 9 Preparation of Articles .............................................................. 3 Further Information ................................................................. 12 Post-Acceptance ......................................................................... 7 ABOUT THE JOURNAL Aims and Scope Journal Details Editor-in-Chief Mucosal Immunology is the official publication of the Society Brian L. Kelsall, MD of Mucosal Immunology (SMI). It aims to provide a forum Chief, Mucosal Immunology Section, Laboratory of for both basic and clinical scientists to discuss all aspects of Molecular Immunology immunity and inflammation involving mucosal tissues. The National Institute of Allergy and Infectious Diseases journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, Deputy Editors and genitourinary immunology through the publication of William Agace original research articles, scholarly reviews, and timely Lund University commentaries, editorials and letters. Publication of basic, translational, and clinical studies will all be given equal Nadine Cerf-Bensussan consideration. Institute National de la Santéet de la Recherche (INSERM) IMAGINE Institute at Université Paris Descartes In addition, Mucosal Immunology aims to provide a primary method of communication for the SMI governing board and Marsha Wills-Karp its members through the publication of society news, Johns Hopkins University announcements of planned meetings and conferences, discussions of policy concerns, and advertisements for job Co-Managing Editors and training opportunities. Jason Roberts Denise Gibson Send an e-mail to the journal Submission of manuscripts Please visit the online submission site to submit a manuscript to the journal. Last updated October 2017 1 ARTICLE TYPE SPECIFICATIONS Unsolicited Word Limit/ Article Description Abstract considered? Tables/Figures 5,000 words Article excluding Abstract, Contributors of original research should review Unstructured References, “Key factors for publication consideration in Abstract of Yes Tables and original research,” below. All submissions of max 200 words Figures; original research will be judged against these References: 50 criteria. max; Figures/ Tables: 10 max 2,500-6,000 words including Abstract Reviews are but excluding Review usually solicited by References, Tables the Editors. and Figures. Comprehensive analyses of specific topics in Proposals for Unstructured Figures of invited mucosal immunology. Both solicited and reviews may be Abstract of reviews have the unsolicited review articles will undergo peer submitted via the max 150 words option of being review prior to acceptance. Editorial Office; illustrated on a outlines of the gratis basis by the proposed paper are publisher. preferred. No max References. Comment No Abstract Typically highlight findings of a manuscript in 1,600 words required; the same or past issues of Mucosal Immunology. Only by invitation excluding however, Also include short manuscripts that address of Editors; References, Tables manuscripts findings published elsewhere or more general however, and Figures; should include topics that are pertinent and timely. proposals may be References: 10 an Commentaries can include opinions or pointed submitted to the max; Introduction of discussions that address controversial topics, or Editorial Office. Figures/Tables: 2 max 75 words. that present new hypotheses. max Correspondence 400 words excluding Typically should address issues concerning References, No Abstract recently published information in Mucosal Tables and required Immunology. A Letter to the Editor must Yes Figures; reference the original source, and a Response References: 5 must reference the Letter to the Editor in the first max; few paragraphs. Letters to the Editor can use an Figures/Tables: arbitrary title, but a Response must cite the title 1 max of the Letter (eg, “Response to [Title of Letter]”) 1,600 words Only by excluding invitation of References, Editors; Editorials Tables, and No Abstract however, Figures; required proposals may References: 5 Proposals for Editorials may be submitted. be submitted to max; the Editorial Figures/Tables: Office. 1 max Last updated October 2017 2 Should be accompanied Images by a brief one- paragraph No Abstract description of Illustrative images which are unique or highly Yes illustrative of specific occurrences in mucosal required max 200 words immunology. They will be reviewed by the of relevant Editorial Board prior to acceptance. clinical or basic scientific information. 1,000 words excluding News References, Only by No Abstract Tables and invitation of required Figures; Timely briefings and analysis on a wide range of Editors. topics important to the field of Immunology. References: 10 max; Figures/Tables: 1 max KEY CONSIDERATIONS AND PREPARATION OF ARTICLES cohorts. Purely in vitro experiments will be given Key factors for publication of original research low priority and may be immediately rejected without formal review. Mucosal Immunology receives many more submissions than • Human studies. Manuscripts providing novel it can publish each month. Therefore, submitted insights into human disease processes will be given manuscripts are critically evaluated according to the high priority. These include studies of basic following criteria: immunological and/or disease mechanisms, as well as functional studies of gene mutations or • Data reproducibility. Original data must include polymorphisms. Manuscripts providing primary adequate evidence of reproducibility. An accurate results of clinical trials are currently not within the description of each set of data that is shown must scope of the journal. be provided and must include the number of biological replicates, the number of experiments • Vaccine studies. Manuscripts evaluating novel performed, and the description and use of vaccine candidates will be considered. However, appropriate statistical methods. The editors will acceptable studies will need to include evidence of not accept representative single experiments in vivo protection in humans or a relevant animal without the author’s written agreement to make model of infection, direct experimental evidence available all of the replicate data upon request. providing a valid comparison with existing Manuscripts submitted without evidence of vaccines, and/or insights into basic immunological reproducibility will be rejected without formal mechanisms. review. • Invertebrate immunology. Studies that provide novel • Novelty. Original findings should represent a insight into human or vertebrate immunology and major advance in the respective field. Data disease will be considered. providing only an incremental advance or extension of prior work will be given low priority. • Genetic studies. Studies of gene expression patterns or identification of disease-associated • Scope. Only manuscripts that include a substantive polymorphisms or mutations without experiments body of work will be considered. In most cases exploring the biological relevance of the findings this will include a primary observation together will be given low priority. with data providing mechanistic insight. Purely descriptive studies will be given low priority. General manuscript preparation • In vivo validation. Higher priority for publication will be given to findings that are validated in well- Manuscripts must be typed in English and double-spaced. established animal models and/or by studies of All manuscript pages must be numbered. relevant immune processes in humans or patient Last updated October 2017 3 In terms of file formats, please use a common word- please see this article. Common mucosal immunology processing package (such as Microsoft Word*) for the text. abbreviations are: Tables should be provided at the end of the Word document. PDFs are not acceptable as manuscript files. *Microsoft Office 2007 saves files in an XML format by BAL bronchoalveolar lavage default (file extensions .docx, .pptx and xlsx). Files saved in this format cannot be accepted for publication. Save Word BALT bronchus-associated lymphoid tissue documents using the file extension .doc CLN cervical lymph node • Select the Office Button in the upper left corner of the Word 2007 Window and choose "Save As" FAE follicle-associated epithelium • Select "Word 97-2003 Document" • Enter a file name and select "Save" GALT gut-associated lymphoid tissue These instructions also apply for the new versions of Excel and PowerPoint. Equations in Word must be created using ILF isolated lymphoid follicle Equation Editor 3.0. Equations created using the new equation editor in Word 2007 and saved as a "Word 97-2003 J chain joining chain Document" (.doc) are converted to graphics and can no longer be edited. To insert or change an equation with the LP lamina propria previous equation editor: MAdCAM- mucosal addressin cell adhesion molecule-1 • Select "Object" on the "Text" section of the "Insert" 1 tab • In the drop-down menu - select "Equation Editor MALT mucosa-associated lymphoid tissue 3.0" MLN mesenteric lymph node Do not use the "Equation" button
Load more

Recommended publications
  • Associated Lymphoid Tissue in Chickens and Turkeys Andrew Stephen Fix Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1990 The trs ucture and function of conjunctiva- associated lymphoid tissue in chickens and turkeys Andrew Stephen Fix Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Animal Sciences Commons, and the Veterinary Medicine Commons Recommended Citation Fix, Andrew Stephen, "The trs ucture and function of conjunctiva-associated lymphoid tissue in chickens and turkeys " (1990). Retrospective Theses and Dissertations. 9496. https://lib.dr.iastate.edu/rtd/9496 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORMATION TO USERS The most advanced technology has been used to photograph and reproduce this manuscript from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. Hie quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
    [Show full text]
  • The Evolution of Nasal Immune Systems in Vertebrates
    Molecular Immunology 69 (2016) 131–138 Contents lists available at ScienceDirect Molecular Immunology j ournal homepage: www.elsevier.com/locate/molimm The evolution of nasal immune systems in vertebrates ∗ Ali Sepahi, Irene Salinas Center for Evolutionary and Theoretical Immunology, Department of Biology, University of New Mexico, Albuquerque, NM, USA a r t i c l e i n f o a b s t r a c t Article history: The olfactory organs of vertebrates are not only extraordinary chemosensory organs but also a powerful Received 15 July 2015 defense system against infection. Nasopharynx-associated lymphoid tissue (NALT) has been traditionally Received in revised form 5 September 2015 considered as the first line of defense against inhaled antigens in birds and mammals. Novel work in Accepted 6 September 2015 early vertebrates such as teleost fish has expanded our view of nasal immune systems, now recognized Available online 19 September 2015 to fight both water-borne and air-borne pathogens reaching the olfactory epithelium. Like other mucosa- associated lymphoid tissues (MALT), NALT of birds and mammals is composed of organized lymphoid Keywords: tissue (O-NALT) (i.e., tonsils) as well as a diffuse network of immune cells, known as diffuse NALT (D- Evolution NALT). In teleosts, only D-NALT is present and shares most of the canonical features of other teleost Nasal immunity NALT MALT. This review focuses on the evolution of NALT in vertebrates with an emphasis on the most recent Mucosal immunity findings in teleosts and lungfish. Whereas teleost are currently the most ancient group where NALT has Vertebrates been found, lungfish appear to be the earliest group to have evolved primitive O-NALT structures.
    [Show full text]
  • Mucosal Immunity
    Mucosal Immunity Lloyd Mayer, MD ABSTRACT. Food allergy is the manifestation of an antibody, secretory immunoglobulin A (sIgA), which abnormal immune response to antigen delivered by the is highly suited for the hostile environment of the gut oral route. Normal mucosal immune responses are gen- (Fig 1). All of these in concert eventuate in the im- erally associated with suppression of immunity. A nor- munosuppressed tone of the gastrointestinal (GI) mal mucosal immune response relies heavily on a num- tract. Defects in any individual component may pre- ber of factors: strong physical barriers, luminal digestion dispose to intestinal inflammation or food allergy. of potential antigens, selective antigen sampling sites, and unique T-cell subpopulations that effect suppres- sion. In the newborn, several of these pathways are not MUCOSAL BARRIER matured, allowing for sensitization rather than suppres- The mucosal barrier is a complex structure com- sion. With age, the mucosa associated lymphoid tissue posed of both cellular and noncellular components.5 matures, and in most individuals this allows for genera- Probably the most significant barrier to antigen entry tion of the normal suppressed tone of the mucosa asso- into the mucosa-associated lymphoid tissue (MALT) ciated lymphoid tissue. As a consequence, food allergies are largely outgrown. This article deals with the normal is the presence of enzymes starting in the mouth and facets of mucosal immune responses and postulates how extending down to the stomach, small bowel, and the different processes may be defective in food-allergic colon. Proteolytic enzymes in the stomach (pepsin, patients. Pediatrics 2003;111:1595–1600; gastrointestinal papain) and small bowel (trypsin, chymotrypsin, allergy, food allergy, food hypersensitivity, oral tolerance, pancreatic proteases) perform a function that they mucosal immunology.
    [Show full text]
  • Mucosal Immunity Learning Goal
    Host Defense 2013 Mucosal Immunity April 16, 2013 Katherine L.Knight, Ph.D. MUCOSAL IMMUNITY LEARNING GOAL You will be able to describe the mucosal immune system. OBJECTIVES To attain the goal for this lecture you will be able to: Describe the components of the mucosal immune system. Draw the structure of secretory IgA. Explain the mechanism of IgA transport across mucosal surfaces. Explain how a response to antigen is generated in the mucosal system. Identify the differences in tolerogenic versus immunogenic responses to mucosal antigen administration. Delineate the functions of the mucosal immune system, including M cells. Describe how the mucosal immune system might be used for immunization. Describe the characteristics of selective IgA deficiency. Describe how intestinal commensal bacteria interact with the host to promote a healthy environment READING ASSIGNMENT Janeway’s Immunobiology 8th Edition (2012), Chapter 12 and Article “Mucosal Immunity and Vaccines” by Robyn Seipp attached at end of lecture notes. LECTURER Katherine L. Knight, Ph.D. Page 1 Host Defense 2013 Mucosal Immunity April 16, 2013 Katherine L.Knight, Ph.D. CONTENT SUMMARY I. INTRODUCTION TO MUCOSAL IMMUNITY II. ORGANIZATION OF THE MUCOSAL IMMUNE SYSTEM A. Components of the Mucosal Immune System B. Induction of a Response C. Features of Mucosal Immunity D. Intraepithelial lymphocytes (IEL) III. IgA SYNTHESIS, STRUCTURE AND TRANSPORT IV. FUNCTIONS OF IgA AT MUCOSAL SURFACES A. Barrier Functions B. Intraepithelial Viral Neutralization C. Excretory Immunity D. Passive Immunity E. IgA Deficiency State V. MUCOSAL IMMUNIZATION VI. MUCOSAL TOLERANCE A. The Induction of Tolerance via Mucosal Sites B. The interaction Between Gut Bacteria and the Intestine I.
    [Show full text]
  • The Role of Intestinal Microbiota and the Immune System
    European Review for Medical and Pharmacological Sciences 2013; 17: 323-333 The role of intestinal microbiota and the immune system F. PURCHIARONI, A. TORTORA, M. GABRIELLI, F. BERTUCCI, G. GIGANTE, G. IANIRO, V. OJETTI, E. SCARPELLINI, A. GASBARRINI Department of Internal Medicine, School of Medicine, Catholic University of the Sacred Heart, Gemelli Hospital, Rome, Italy Abstract. – BACKGROUND: The human gut Introduction is an ecosystem consisting of a great number of commensal bacteria living in symbiosis with the The intestinal microbiota is composed of 1013-14 host. Several data confirm that gut microbiota is engaged in a dynamic interaction with the in- microorganisms (Figure 1), with at least 100 testinal innate and adaptive immune system, af- times as many genes as our genome, the micro- fecting different aspects of its development and biome. Its composition is individual-specific, function. ranges among individuals and also within the AIM: To review the immunological functions same individual during life. Many factors can in- of gut microbiota and improve knowledge of its fluence the gut flora composition, as diet, age, therapeutic implications for several intestinal medications, illness, stress and lifestyle. The gas- and extra-intestinal diseases associated to dys- regulation of the immune system. trointestinal (GI) tract contains both “friendly” METHODS: Significant articles were identified bugs, such as Gram-positive Lactobacilli and Bi- by literature search and selected based on con- fidobacteria dominate (> 85% of total bacteria), tent, including atopic diseases, inflammatory and potential pathogenic bacteria, coexisting in a bowel diseases and treatment of these condi- complex symbiosis. Several evidences show that tions with probiotics.
    [Show full text]
  • Terminology: Nomenclature of Mucosa-Associated Lymphoid Tissue
    nature publishing group ARTICLES See COMMENTARY page 8 See REVIEW page 11 Terminology: nomenclature of mucosa-associated lymphoid tissue P B r a n d t z a e g 1 , H K i y o n o 2 , R P a b s t 3 a n d M W R u s s e l l 4 Stimulation of mucosal immunity has great potential in vaccinology and immunotherapy. However, the mucosal immune system is more complex than the systemic counterpart, both in terms of anatomy (inductive and effector tissues) and effectors (cells and molecules). Therefore, immunologists entering this field need a precise terminology as a crucial means of communication. Abbreviations for mucosal immune-function molecules related to the secretory immunoglobulin A system were defined by the Society for Mucosal Immunolgy Nomenclature Committee in 1997, and are briefly recapitulated in this article. In addition, we recommend and justify standard nomenclature and abbreviations for discrete mucosal immune-cell compartments, belonging to, and beyond, mucosa-associated lymphoid tissue. INTRODUCTION for dimers (and larger polymers) of IgA and pentamers of It is instructive to categorize various tissue compartments IgM was proposed in 1974. 3,4 The epithelial glycoprotein involved in mucosal immunity according to their main function. designated secretory component (SC) by WHO in 1972 However, until recently, there was no consensus in the scientific (previously called “ transport piece ” or “ secretory piece ” ) turned community as to how these compartments should be named and out to be responsible for the receptor-mediated transcytosis classified. This lack of standardized terminology has been particu- of J-chain-containing Ig polymers (pIgs) through secretory larly confusing for newcomers to the mucosal immunology field.
    [Show full text]
  • 1 Polysaccharide A-Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides Fragilis in T
    Page 1 of 44 Diabetes Polysaccharide A-dependent opposing effects of mucosal and systemic exposures to human gut commensal Bacteroides fragilis in type 1 diabetes M. Hanief. Sofi1, Benjamin M. Johnson1, Radhika R. Gudi1, 1, Amy Jolly1, Marie-Claude Gaudreau1, and Chenthamarakshan Vasu1,3 1Microbiology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, SC-29425 3Surgery, College of Medicine, Medical University of South Carolina, Charleston, SC-29425 Running title: Bacteroides fragilis in type 1 diabetes. 5Address Correspondence: Chenthamarakshan Vasu Microbiology and Immunology Medical University of South Carolina 173 Ashley Avenue, BSB208E Charleston, SC-29425 Phone: 843-792-1032, Fax: 843-792-9588 Email: [email protected] 1 Diabetes Publish Ahead of Print, published online July 16, 2019 Diabetes Page 2 of 44 Abstract Bacteroides fragilis (BF) is an integral component of the human colonic commensal microbiota. BF is also the most commonly isolated organism from clinical cases of intra-abdominal abscesses suggesting its potential to induce pro-inflammatory responses, upon accessing the systemic compartment. Hence, we examined the impact of mucosal and systemic exposures to BF on type 1 diabetes (T1D) incidence in non-obese diabetic (NOD) mice. The impact of intestinal exposure to BF under chemically-induced enhanced gut permeability condition, which permits microbial translocation, in T1D was also examined. While oral administration of pre- diabetic mice with heat-killed (HK) BF caused enhanced immune regulation and suppression of autoimmunity resulting in delayed hyperglycemia, mice that received HK BF by i.v. injection showed rapid disease progression. Importantly, polysaccharide-A deficient (ΔPSA) BF failed to produce these opposing effects upon oral and systemic deliveries.
    [Show full text]
  • The Future of Mucosal Immunology: Studying an Integrated System-Wide Organ
    cOmmEntARY The future of mucosal immunology: studying an integrated system-wide organ Navkiran Gill, Marta Wlodarska & B Brett Finlay Over the next 10 years, it will be important to shift the focus of mucosal immunology research to make further advances. Examination of the mucosal immune system as a global organ, rather than as a group of individual components, will identify and characterize relationships between mucosal sites. he term ‘common mucosal immunological Tsystem’ was coined by John Bienenstock a nearly 40 years ago. He suggested the con- cept when the bronchus-associated lymphoid tissues his group described were found to be Oral Airway epithelium Antigen epithelium similar to those in the gastrointestinal tract. Fibroblasts Ironically, appreciation of the importance of Smooth muscle T 2T this term is only now truly beginning. Since H reg Treg DC then, the mucosal immune system has received MHC B B Mast cell a great deal of attention and is described as an integrated network of tissues, cells and effector Cervical AMPs Lumen molecules that protect the host from infection Virus epithelium b Intestinal and environmental insult at mucous membrane epithelium Health Disease surfaces. Mucosal surfaces are immunologically Goblet cell Signals Microbial unique, as they act as the primary interface TH2 T 1 H B cell community between the host and the physical environ- T cell T 17 © 2010 Nature America, Inc. All rights reserved. All rights Inc. America, Nature © 2010 H ment yet also have key barrier functions. It Treg has become increasingly evident that mucosal surfaces are also the main sites of interaction IEC- Mucins between the host and its associated commen- Tolerance Inflammation associated microbial Lamina sal microbial community.
    [Show full text]
  • Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
    Synopses Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases Frederik W. van Ginkel, Huan H. Nguyen, and Jerry R. McGhee The University of Alabama at Birmingham, Birmingham, Alabama, USA The mucosal immune system consists of molecules, cells, and organized lymphoid structures intended to provide immunity to pathogens that impinge upon mucosal surfaces. Mucosal infection by intracellular pathogens results in the induction of cell- mediated immunity, as manifested by CD4-positive (CD4+) T helper-type 1 cells, as well as CD8+ cytotoxic T-lymphocytes. These responses are normally accompanied by the synthesis of secretory immunoglobulin A (S-IgA) antibodies, which provide an important first line of defense against invasion of deeper tissues by these pathogens. New- generation live, attenuated viral vaccines, such as the cold-adapted, recombinant nasal influenza and oral rotavirus vaccines, optimize this form of mucosal immune protection. Despite these advances, new and reemerging infectious diseases are tipping the balance in favor of the parasite; continued mucosal vaccine development will be needed to effectively combat these new threats. Behavioral changes in the human host may would most likely be prevalent under current be contributing to the emergence of new diseases. conditions. Pathogens in this category include Perhaps emerging pathogens become resistant to respiratory viruses, for example, influenza virus. antibiotics or (through genetic recombination) Another group includes sexually transmitted become more resistant to host defenses. disease (STD) pathogens, for example, HIV. The Recombination events or lack of exposure can fact that a) pneumonia and influenza virus and b) result in loss of immunity of the population to the HIV infection were listed as the leading causes of pathogen, as has been well documented with death (ranked number 6 and 8, respectively) by influenza virus.
    [Show full text]
  • Secretory Iga in Intestinal Mucosal Secretions As an Adaptive Barrier Against Microbial Cells
    International Journal of Molecular Sciences Review Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells Bernadeta Pietrzak 1,* , Katarzyna Tomela 2 , Agnieszka Olejnik-Schmidt 1 , Andrzej Mackiewicz 2,3 and Marcin Schmidt 1,* 1 Department of Food Biotechnology and Microbiology, Poznan University of Life Sciences, 48 Wojska Polskiego, 60-627 Pozna´n,Poland; [email protected] 2 Department of Cancer Immunology, Chair of Medical Biotechnology, Poznan University of Medical Sciences, 8 Rokietnicka Street, 60-806 Pozna´n,Poland; [email protected] (K.T.); [email protected] (A.M.) 3 Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 15 Garbary Street, 61-866 Pozna´n,Poland * Correspondence: [email protected] (B.P.); [email protected] (M.S.) Received: 2 November 2020; Accepted: 2 December 2020; Published: 4 December 2020 Abstract: Secretory IgA (SIgA) is the dominant antibody class in mucosal secretions. The majority of plasma cells producing IgA are located within mucosal membranes lining the intestines. SIgA protects against the adhesion of pathogens and their penetration into the intestinal barrier. Moreover, SIgA regulates gut microbiota composition and provides intestinal homeostasis. In this review, we present mechanisms of SIgA generation: T cell-dependent and -independent; in different non-organized and organized lymphoid structures in intestinal lamina propria (i.e., Peyer’s patches and isolated lymphoid follicles). We also summarize recent advances in understanding of SIgA functions in intestinal mucosal secretions with focus on its role in regulating gut microbiota composition and generation of tolerogenic responses toward its members.
    [Show full text]
  • The Role of Gut-Associated Lymphoid Tissues and Mucosal Defence
    Downloaded from https://www.cambridge.org/core British Journal of Nutrition (2005), 93, Suppl. 1, S41–S48 DOI: 10.1079/BJN20041356 q The Authors 2005 The role of gut-associated lymphoid tissues and mucosal defence . IP address: 1,2 2,3 Maria Luisa Forchielli and W. Allan Walker * 170.106.33.42 1Department of Pediatrics, University of Bologna, Bologna, Italy 2Department of Pediatrics, Harvard Medical School, Boston, MA, USA 3 Harvard Medical School, Mucosal Immunology Laboratories, Massachusetts General Hospital, Boston, MA, USA , on 29 Sep 2021 at 20:56:49 The newborn infant leaves a germ-free intrauterine environment to enter a contaminated extrauterine world and must have adequate intestinal defences to prevent the expression of clinical gastrointestinal disease states. Although the intestinal mucosal immune system is fully developed after a full-term birth, the actual protective function of the gut requires the microbial stimulation of initial bacterial colonization. Breast milk contains prebiotic oligosaccharides, like inulin-type fructans, which are not digested in the small intestine but enter the colon as intact large carbohydrates that are then fermented by the resident bacteria to produce SCFA. The nature of this fermentation and the consequent pH of the intestinal contents dictate proliferation of specific resident bacteria. , subject to the Cambridge Core terms of use, available at For example, breast milk-fed infants with prebiotics present in breast milk produce an increased proliferation of bifidobacteria and lactobacilli (probiotics), whereas formula-fed infants produce more enterococci and enterobacteria. Probiotics, stimulated by prebiotic fermentation, are important to the development and sustainment of intestinal defences. For example, probiotics can stimulate the synthesis and secretion of polymeric IgA, the antibody that coats and pro- tects mucosal surfaces against harmful bacterial invasion.
    [Show full text]
  • CRTAM Shapes the Gut Microbiota and Enhances the Severity of Infection Araceli Perez-Lopez, Sean-Paul Nuccio, Irina Ushach, Robert A
    CRTAM Shapes the Gut Microbiota and Enhances the Severity of Infection Araceli Perez-Lopez, Sean-Paul Nuccio, Irina Ushach, Robert A. Edwards, Rachna Pahu, Steven Silva, Albert This information is current as Zlotnik and Manuela Raffatellu of October 3, 2021. J Immunol 2019; 203:532-543; Prepublished online 29 May 2019; doi: 10.4049/jimmunol.1800890 http://www.jimmunol.org/content/203/2/532 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/05/28/jimmunol.180089 Material 0.DCSupplemental References This article cites 60 articles, 15 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/203/2/532.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 3, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CRTAM Shapes the Gut Microbiota and Enhances the Severity of Infection Araceli Perez-Lopez,*,†,‡ Sean-Paul Nuccio,*,†,‡ Irina Ushach,‡,x Robert A.
    [Show full text]